Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Is brain insulin resistance a feature of the biology of depression? A pilot multi-modality neuroimaging study in adolescents

EF 2021-22

Résumé
I will examine whether brain insulin resistance is involved in the pathophysiology of major depressive disorder (MDD). This research question evolved following the observation that MDD is often co-morbid with metabolic dysfunction such as weight gain and type 2 diabetes (T2D), and that insulin resistance is associated with greater depressive symptom severity and worse cognition. To explore this bidirectional relationship, 12 medication-naïve/free MDD patients aged 14 to 18 years old, and 12 age-, sex-, and weight-matched healthy controls, will participate in a single-blind crossover magnetic resonance imaging (MRI) study. This will include completing fasting blood work and two MRI sessions: the first following intranasal placebo, and after a short break, the second following intranasal insulin challenge (80 IU). The MRI sessions will measure insulin induced changes in connectivity, blood flow, and glutamate levels within brain regions of interest using resting state functional MRI, arterial spin labeling, and magnetic resonance spectroscopy, respectively. A brief cognitive assessment and an abdominal surface coil scan will also be performed to measure visceral and hepatic adiposity to identify the relationship between brain insulin resistance and these outcomes. It is hypothesized that brain insulin resistance will be higher in MDD participants compared to the healthy controls, and will also be associated with greater illness severity, worse cognitive performance, and greater hepatic and visceral adiposity. Demonstrating disrupted brain insulin action can provide novel insights into poorly understood mechanisms underlying the relationship between MDD and T2D, and help uncover modifiable risk factors that can be targeted at the earliest stages of the illness.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466627
Name
Maksyutynska Kateryna
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Is brain insulin resistance a feature of the biology of depression? A pilot multi-modality neuroimaging study in adolescents
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adolescents; Brain Insulin Resistance; Cognition; Depression; Functional Mri; Imaging; Intranasal Insulin; Mental Health; Metabolic; Mood Disorders
Abstract
I will examine whether brain insulin resistance is involved in the pathophysiology of major depressive disorder (MDD). This research question evolved following the observation that MDD is often co-morbid with metabolic dysfunction such as weight gain and type 2 diabetes (T2D), and that insulin resistance is associated with greater depressive symptom severity and worse cognition. To explore this bidirectional relationship, 12 medication-naïve/free MDD patients aged 14 to 18 years old, and 12 age-, sex-, and weight-matched healthy controls, will participate in a single-blind crossover magnetic resonance imaging (MRI) study. This will include completing fasting blood work and two MRI sessions: the first following intranasal placebo, and after a short break, the second following intranasal insulin challenge (80 IU). The MRI sessions will measure insulin induced changes in connectivity, blood flow, and glutamate levels within brain regions of interest using resting state functional MRI, arterial spin labeling, and magnetic resonance spectroscopy, respectively. A brief cognitive assessment and an abdominal surface coil scan will also be performed to measure visceral and hepatic adiposity to identify the relationship between brain insulin resistance and these outcomes. It is hypothesized that brain insulin resistance will be higher in MDD participants compared to the healthy controls, and will also be associated with greater illness severity, worse cognitive performance, and greater hepatic and visceral adiposity. Demonstrating disrupted brain insulin action can provide novel insights into poorly understood mechanisms underlying the relationship between MDD and T2D, and help uncover modifiable risk factors that can be targeted at the earliest stages of the illness.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Maksyutynska, Kateryna
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~